Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy: Clinical Studies. - Popat, Sanjay; Januszewski, Adam; O'Brien, Mary; Ahmad, Tanya; Lewanski, Conrad; Dernedde, Ulrike; Jankowska, Petra; Mulatero, Clive; Shah, Riyaz; Hicks, Jonathan; Geldart, Tom; Cominos, Mathilda; et al. (British Journal of Cancer, 2025)